TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion. - Debesset A; Pilon C; Meunier S; Cuelenaere-Bonizec O; Richer W; Thiolat A; Houppe C; Ponzo M; Magnan J; Caron J; Caudana P; Tosello Boari J; et al. (Journal for immunotherapy of cancer, 2024)